We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.50 | 0.98% | 1,599.00 | 1,599.50 | 1,600.50 | 1,600.00 | 1,575.00 | 1,579.50 | 5,149,016 | 16:35:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.37 | 65.87B |
Date | Subject | Author | Discuss |
---|---|---|---|
10/11/2017 13:42 | It paid to do the dividend and sell at 10am yesterday! | che7win | |
10/11/2017 13:13 | I wish a tenner | stevenrevell | |
10/11/2017 12:17 | As it happens it was cheaper not to take the dividend. Could this do a return to a tenner I ask myself | 1fox1 | |
10/11/2017 12:12 | Sorry to say, but on technicals, this stock is in a downtrend on virtually all timeframes, except the monthly. Long term investors should not consider buying into the stock until price at least breaks out of 1367 (daily chart pullback break...as of today. The breakout level will change over time), which would entice professional traders to go long. This would give the stock a breather and a chance to retrace back to 1544 or least somewhere in between until the pullback on the daily ends. Until the stock breaks out on the daily chart, only intraday traders and position traders will be able to play the stock using complex risk management strategies. Next MAJOR technical support is at 1227 on the monthly chart. 1300 may offer psychological support with an opportunity for the shorters to consolidate, creating buying demand. Whether it will hold remains to be seen. I am a day trader, trading multiple timeframes. Research based on Technical Analysis and high probability trading. Please DYOR. | mani2013 | |
10/11/2017 12:00 | Support around 1330-1328 should hold | mj19 | |
10/11/2017 11:39 | Will add some more soon, come out of more risky but hugely profitable stocks, happy to ride any market correction out with a number quality high yielding divi players | ny boy | |
10/11/2017 11:33 | Annoying I know like I said no update till next year , xdivi date has gone till next quarter we need good news and people will start to buy this again. Not sure whether to top up now ... need to see some strength in the share price | mj19 | |
10/11/2017 11:27 | down 16 yesterday and 7 today dividend more than wiped out | billionaire1 | |
10/11/2017 11:24 | I think the average broker view is 1610 be nice to get close to that | mj19 | |
10/11/2017 11:22 | JP MORGAN price cut doesn't help - from gbx 1570 to 1330 | mj19 | |
10/11/2017 11:10 | Yes the share price might slip slowly until there is news about growth... we need some positive news.. | mj19 | |
10/11/2017 10:55 | What will get cheaper? The share price? I don't think so. The stock is grossly oversold and heavily talked down following Emma's presentation. The results were strong and there's been major good news for blockbuster approvals since then. The company will not bid for a large consumer healthcare business that it can't afford and does not need, so until that noise settles the company will continue to grow profits despite a temporarily depressed share price. | tradermichael | |
10/11/2017 10:29 | How cheaper tho that's the thing | stevenrevell | |
10/11/2017 10:25 | It will get cheaper as many people wait to see how things pan out. Growth is key here... | mj19 | |
10/11/2017 08:11 | Not to bad, 1350p add 19p ex div yesterday now 1369p look at it that way, lol | montyhedge | |
10/11/2017 07:43 | As earnings grow, the act of not increasing the dividend reduces the need to make a cut. The company has two recently approved blockbusters and more in the pipeline. | tradermichael | |
09/11/2017 21:48 | Very sound words MJ19... | zorija | |
09/11/2017 19:13 | Just be careful be in this for the long term things could get tricky going forwardThis explains whyIt is likely that there will be some big changes at GlaxoSmithKline during the coming years. The company is considering acquisitions in the consumer healthcare space, while already carrying a large debt and paying a very generous dividend. GSK can not have it all: either potential acquisitions or the dividend will have to suffer. As the situation is now, I expect the dividend to be cut in 2019, even when the company does not do any acquisition. When GSK makes some intelligent choices, the company will be able to grow at a quicker rate, repay some debt and restore the dividend eventually. But for this, shareholders need to be patient.GlaxoSmithKl | mj19 | |
09/11/2017 15:18 | Is it ex dividend date today. If so I'm too late. Doh :o( | sooty snipes | |
09/11/2017 14:36 | Might close down 19 at this rate | mj19 | |
09/11/2017 11:44 | It will be £7285 for 38,343 shares ..... LOL | tradermichael | |
09/11/2017 10:39 | MT, must be another 5k plus for you today, the bank of Michael eh ) | essentialinvestor | |
09/11/2017 10:35 | Its not always the case that the price falls (even at opening)by the dividend amount on xd morning. For GSK it has gone up through the day several times in the past, depending on market activity ...... ;o) | tradermichael | |
09/11/2017 09:49 | It was marked down, but the price has since risen - trading is as usual, just like any other day. | woodhawk |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions